Editor's PickMarket News

Universal Ibogaine retains co-founder Shayne Nyquvest as capital markets advisor

Universal Ibogaine Inc (TSX-V:IBO) told investors that it has retained Shayne Nyquvest in a consulting role as capital markets advisor.  Nyquvest, a co-founder of the company, has extensive capital markets experience, with over 40 years of involvement in aiding companies’ strategic fund-raising activities, in the mining, cannabis and other emerging industries, the life sciences group said.  He served as the former executive vice-president of investment banking firm Mackie Research Capital, where he worked from June 2015 to July 2018 and was a founding member of Canaccord Genuity Group, where he worked as a senior investment advisor from 1993 to 2013.  READ: Universal Ibogaine eyeing resumption of operations after Kelburn Recovery Centre flood “We are pleased to have Shayne re-engaged in our strategic, business development goals,” the company’s CEO Nick Karos said in a statement. “He has an extensive network in the investment community and was instrumental in UI’s early-stage financing and research activities.” Nyquvest co-founded Universal Ibogaine in early 2018, after personally seeing the transformational effects and potential of ibogaine and was involved in the company’s early-stage development until mid-2021. The company said Nyquvest’s vision has been to see this innovative, plant-based treatment adopted by the mainstream medical community as a solution to helping break the opioid epidemic and other addictions. “We continue to advance our planned Health Canada clinical trials application for the use of ibogaine in opioid use disorder and expect to provide additional updates on this in the near future,” Karos added. Universal Ibogaine’s mission is to demonstrate the safety and efficacy of its ibogaine based drug detox protocol through a planned Canadian Clinical Trial (focused on opioid use disorder), and ultimately to utilize that protocol around the globe through planned future licensing agreements.  The company is concurrently developing a state of the art holistic addiction treatment protocol at its Kelburn Recovery Centre that, when paired with the planned ibogaine detox protocol, is intended to revolutionize the way we treat addiction and drastically improve the lives of individuals and families affected by addiction. Contact the author at stephen.gunnion@proactiveinvestors.com